BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 29356966)

  • 1. Pheochromocytomas and Hypertension.
    Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
    Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of pheochromocytoma: a practical guide to clinicians.
    Pappachan JM; Raskauskiene D; Sriraman R; Edavalath M; Hanna FW
    Curr Hypertens Rep; 2014 Jul; 16(7):442. PubMed ID: 24792093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of paragangliomas.
    Corssmit EP; Romijn JA
    Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma: presentation, diagnosis and treatment.
    Reisch N; Peczkowska M; Januszewicz A; Neumann HP
    J Hypertens; 2006 Dec; 24(12):2331-9. PubMed ID: 17082709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
    Jain A; Baracco R; Kapur G
    Pediatr Nephrol; 2020 Apr; 35(4):581-594. PubMed ID: 30603807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pheochromocytoma - still a challenge].
    Reisch N; Walz MK; Erlic Z; Neumann HP
    Internist (Berl); 2009 Jan; 50(1):27-35. PubMed ID: 19099277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pheochromocytomas and secreting paragangliomas.
    Plouin PF; Gimenez-Roqueplo AP
    Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pheochromocytomas and Paragangliomas.
    Tevosian SG; Ghayee HK
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phaeochromocytoma and paraganglioma].
    Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
    Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytoma.
    Manger WM; Gifford RW
    J Clin Hypertens (Greenwich); 2002; 4(1):62-72. PubMed ID: 11821644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of pheochromocytoma.
    Gifford RW; Bravo EL; Manger WM
    Cardiology; 1985; 72 Suppl 1():126-30. PubMed ID: 2865007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phaeochromocytoma and Paraganglioma.
    Gunawardane PTK; Grossman A
    Adv Exp Med Biol; 2017; 956():239-259. PubMed ID: 27888488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The sympathetic system and neuroendocrine hypertension].
    Zuccala' A; Di Nicolo' P; Fiorenza S; Lifrieri F; Rapana' R
    G Ital Nefrol; 2008; 25(2):203-14. PubMed ID: 18350500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in diagnosis and treatment of pheochromocytoma.
    Veglio F; Morello F; Morra Di Cella S; Del Colle S; Rabbia F; Mulatero P
    Minerva Med; 2003 Aug; 94(4):267-71. PubMed ID: 14605591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaeochromocytomas and functional paragangliomas: clinical management.
    Plouin PF; Amar L; Lepoutre C
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):933-41. PubMed ID: 21115162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of tumors of the adrenal medulla.
    Ilias I; Pacak K
    Horm Metab Res; 2005 Dec; 37(12):717-21. PubMed ID: 16372223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.
    Patel HV; Srivastava A; Becker MD; Beninato T; Laird AM; Singer EA
    Curr Urol Rep; 2021 Jan; 22(1):2. PubMed ID: 33403502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach.
    Andersen KF; Altaf R; Krarup-Hansen A; Kromann-Andersen B; Horn T; Christensen NJ; Hendel HW
    Cancer Treat Rev; 2011 Apr; 37(2):111-9. PubMed ID: 20675056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
    Chrisoulidou A; Kaltsas G; Ilias I; Grossman AB
    Endocr Relat Cancer; 2007 Sep; 14(3):569-85. PubMed ID: 17914089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.